U.S. FDA Releases Literature Review of Radiofrequency Radiation and Cancer

The U.S. Food and Drug Administration (FDA) has released a comprehensive report summarizing the results of more than 10 years of scientific and epidemiological studies on the potential adverse health effects of exposure to radiofrequency (RF) radiation.  

Published earlier this month, the report, entitled “Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer,” reviewed more than 125 peer-reviewed articles published between January 1, 2008 and mid-2018 to assess the possible causal relationship between exposure to RF radiation in the frequency range of 100 KHz to 6 GHz and the formation of cancerous tumors.

The FDA’s conclusion?  “There is insufficient evidence to support a causal association between RF radiation exposure and tumorigenesis.” Further, “there are no quantifiable adverse health effects in humans caused by exposures at or under the current cell phone exposure limits.”

Read the complete text of the FDA’s literature review related to radiofrequency radiation exposure and cancer.

Leave a Reply

Your email address will not be published.